热门资讯> 正文
MangoRx收到澳大利亚专利申请受理通知
2024-06-06 21:47
- Mangoceuticals (NASDAQ:MGRX) on Thursday announced that it received a notice of acceptance from the Australian patent authority.
- The notice of acceptance covers the proprietary formulation and application methods designed to combat a wide range of infections, including common colds, respiratory diseases, and orally transmitted infections such as human papillomavirus, the company added.
- Acceptance of the application will officially be published in the Australian Official Journal of Patents on June 6, 2024.
- Source: Press Release
More on Mangoceuticals
- Mangoceuticals stock rallies on Japanese patent allowance
- Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds
- Financial information for Mangoceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
